Key result
NOACs demonstrate potential to replace VKAs and impact mortality in critical leg ischemia.
Key points are not available for this paper at this time.
Should not change anticoagulation practice in critical leg ischemia; hypothesis-generating for NOAC mortality benefit versus vitamin K antagonists.
mortality and its predictor's inpatients with critical leg ischaemia.
No takes yet. Share an insight, caveat, or question.
Wrigley et al. (2010) studied this question. Novel oral anticoagulants demonstrate the potential to replace vitamin K antagonists in clinical practice, potentially impacting mortality in patients with critical leg ischemia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: